Nuvectis Pharma, Inc.

For the period ended Dec 31, 2025. Filed Feb 11, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 11, 2026

NVCT$20.91+17.7%Stored close · as of Nov 6, 2026

Opening this filing…